News & Stories
As the U.S. cuts critical aid programs, millions face dire consequences. Canada’s leadership in global health and aid is vital to supporting vulnerable communities and upholding our shared values.
On October 3, 2024, a gang attack in Pont-Sondé, Haiti, forced thousands to flee. Saint-Nicolas Hospital, supported by Zanmi Lasante, mobilized rapidly to treat victims, despite resource shortages.
A timeline tracking the PIH co-founder’s contributions to improving TB treatment, research, and policy globally.
Vicky Reed, a dedicated nurse and leader, was appointed Executive Director of PIH Sierra Leone in August 2024. She aims to improve healthcare access and strengthen systems for vulnerable communities.
Partners In Health opens a 32-bed maternal waiting home in Lesotho to reduce maternal mortality. The facility provides expectant mothers with safe, supported childbirth in remote areas.
In Malawi, a groundbreaking program by Partners In Health (PIH) is transforming cardiac care for patients suffering from severe heart conditions. Through specialized treatment at Neno District Hospital, patients now receive lifesaving interventions, including surgeries and long-term care that were previously unavailable in the region. The initiative addresses a critical health gap, offering hope to those battling heart disease, and ensuring they receive the quality care they deserve.
A new oxygen production centre in Saint-Marc, Haiti, is revolutionizing health care for underserved communities. Led by Partners In Health, the facility ensures a reliable supply of life-saving oxygen to hospitals and clinics, improving patient outcomes and reducing reliance on costly imports. This initiative brings essential resources to areas in critical need, offering hope and better health care access across the region.
In true back-to-school fashion, the PIHC team recommended five articles, books, and novels on the intersections of global health, social justice, and the social determinants of health.
New WHO-approved TB treatments from the PIH-led endTB trial offer shorter, safer regimens for multidrug-resistant TB, benefiting vulnerable groups like children and pregnant women. These treatments can reduce transmission and save lives globally.